Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
Qsam Biosciences Inc (QSAM)QSAM
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
Stock price based out of last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
05/02/2024: QSAM (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Upturns
Type: Stock | Upturn Star Rating | Today’s Advisory: Consider higher Upturn Star rating |
Profit: -81.06% | Upturn Advisory Performance  2 | Avg. Invested days: 22 |
| Profits based on simulation | Stock Returns Performance  1 | Last Close 05/02/2024 |
Type: Stock | Today’s Advisory: Consider higher Upturn Star rating |
Profit: -81.06% | Avg. Invested days: 22 |
Upturn Star Rating | Stock Returns Performance 1 |
| Profits based on simulation Last Close 05/02/2024 | Upturn Advisory Performance 2 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 36.90M USD |
Price to earnings Ratio - | 1Y Target Price - |
Dividends yield (FY) - | Basic EPS (TTM) -1.69 |
Volume (30-day avg) 11761 | Beta 1.81 |
52 Weeks Range 4.00 - 8.49 | Updated Date 05/3/2024 |
Company Size Small-Cap Stock | Market Capitalization 36.90M USD | Price to earnings Ratio - | 1Y Target Price - |
Dividends yield (FY) - | Basic EPS (TTM) -1.69 | Volume (30-day avg) 11761 | Beta 1.81 |
52 Weeks Range 4.00 - 8.49 | Updated Date 05/3/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) -238.09% | Return on Equity (TTM) -3377.07% |
Valuation
Trailing PE - | Forward PE - |
Enterprise Value 36027704 | Price to Sales(TTM) 1.71 |
Enterprise Value to Revenue 18.26 | Enterprise Value to EBITDA -8.02 |
Shares Outstanding 4445470 | Shares Floating 2065365 |
Percent Insiders 52.36 | Percent Institutions - |
Trailing PE - | Forward PE - | Enterprise Value 36027704 | Price to Sales(TTM) 1.71 |
Enterprise Value to Revenue 18.26 | Enterprise Value to EBITDA -8.02 | Shares Outstanding 4445470 | Shares Floating 2065365 |
Percent Insiders 52.36 | Percent Institutions - |
Analyst Ratings
Rating - | Target Price - | Buy - |
Strong Buy - | Hold - | Sell - |
Strong Sell - |
Rating - | Target Price - | Buy - | Strong Buy - |
Hold - | Sell - | Strong Sell - |
About Qsam Biosciences Inc
| Exchange | NASDAQ | Headquaters | Austin, TX, United States |
| IPO Launch date | 2015-12-11 | Co-Founder, CEO & Director | Mr. Douglas R. Baum |
| Sector | Healthcare | Website | https://qsambio.com |
| Industry | Biotechnology | Full time employees | 4 |
| Headquaters | Austin, TX, United States | ||
| Co-Founder, CEO & Director | Mr. Douglas R. Baum | ||
| Website | https://qsambio.com | ||
| Website | https://qsambio.com | ||
| Full time employees | 4 |
QSAM Biosciences, Inc. engages in developing various nuclear medicines for the treatment of cancer. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage bone targeting radiopharmaceutical. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc. and changed its name to QSAM Biosciences, Inc. in September 2020. QSAM Biosciences, Inc. was incorporated in 2004 and is headquartered in Austin, Texas.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.